The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks.
Hypertens Res
; 2024 Jul 01.
Article
in En
| MEDLINE
| ID: mdl-38951682
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Hypertens Res
Journal subject:
ANGIOLOGIA
Year:
2024
Document type:
Article
Affiliation country:
Japan